Xiujun Cai
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Circular RNAs in diseases 12
- RNA modifications and cancer 11
- Hepatology 47
- Hepatocellular Carcinoma Treatment and Prognosis 38
- Co-authors
- Xiao Liang (41 shared papers)Yuelong Liang (28 shared papers)Mingyu Chen (38 shared papers)Hong Yu (28 shared papers)Hui Lin (22 shared papers)Junjie Xu (16 shared papers)Sarun Juengpanich (23 shared papers)Yifan Wang (37 shared papers)
- Journals
- Oncotarget (6 papers)Frontiers in Oncology (6 papers)Journal of Laparoendoscopic & Advanced Surgical Techniques (5 papers)Cell Death and Disease (5 papers)Advanced Science (4 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Xiujun Cai
233 papers receiving 7.3k citations
Xiujun Cai's Hit Papers
Peers
Comparison fields: 5 of 149
- Hepatology 902
- Cancer Research 1.6k
- Molecular Biology 2.9k
- Oncology 997
- Pulmonary and Respiratory Medicine 969
Countries citing papers authored by Xiujun Cai
This map shows the geographic impact of Xiujun Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiujun Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiujun Cai more than expected).
Fields of papers citing papers by Xiujun Cai
This network shows the impact of papers produced by Xiujun Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiujun Cai. The network helps show where Xiujun Cai may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiujun Cai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 244 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Targeting mutant p53 for cancer therapy: direct and indirect strategies Hit paper breakdown → | 2021 | 363 |
| 2 | CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1 Hit paper breakdown → | 2020 | 343 |
| 3 | 2020 | 227 | |
| 4 | 2020 | 223 | |
| 5 | 2015 | 213 | |
| 6 | ZnS@BSA Nanoclusters Potentiate Efficacy of Cancer Immunotherapy Hit paper breakdown → | 2021 | 195 |
| 7 | 2020 | 184 | |
| 8 | 2020 | 183 | |
| 9 | 2020 | 161 | |
| 10 | 2017 | 135 | |
| 11 | 2014 | 133 | |
| 12 | 2020 | 129 | |
| 13 | 2016 | 128 | |
| 14 | 2018 | 122 | |
| 15 | 2015 | 109 | |
| 16 | 2021 | 105 | |
| 17 | 2021 | 97 | |
| 18 | 2021 | 89 | |
| 19 | 2018 | 85 | |
| 20 | 2020 | 85 |
About Xiujun Cai
Xiujun Cai is a scholar working on Molecular Biology, Hepatology, Surgery, Cancer Research and Oncology, having authored 244 papers that have together received 7.3k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (38 papers), Nanoplatforms for cancer theranostics (20 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers), MicroRNA in disease regulation (16 papers), Cancer Mechanisms and Therapy (12 papers), Circular RNAs in diseases (12 papers), RNA modifications and cancer (11 papers) and Cancer-related molecular mechanisms research (10 papers). The work is most often cited by research in Hepatology (902 citations), Cancer Research (1.6k citations), Molecular Biology (2.9k citations), Oncology (997 citations) and Pulmonary and Respiratory Medicine (969 citations). Xiujun Cai has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Xiao Liang, Yuelong Liang, Mingyu Chen, Hong Yu, Hui Lin, Junjie Xu, Sarun Juengpanich, Yifan Wang, Renan Jin and Jiasheng Cao. Their work appears in journals such as Oncotarget, Frontiers in Oncology, Journal of Laparoendoscopic & Advanced Surgical Techniques, Cell Death and Disease and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.